KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Current Assets (2016 - 2026)

Eli Lilly filings provide 18 years of Current Assets readings, the most recent being $54.8 billion for Q1 2026.

  • On a quarterly basis, Current Assets rose 32.9% to $54.8 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $54.8 billion, a 32.9% increase, with the full-year FY2025 number at $55.6 billion, up 69.91% from a year prior.
  • Current Assets hit $54.8 billion in Q1 2026 for Eli Lilly, down from $55.6 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $62.1 billion in Q3 2025 to a low of $17.0 billion in Q1 2022.
  • Median Current Assets over the past 5 years was $25.7 billion (2023), compared with a mean of $32.0 billion.
  • Biggest five-year swings in Current Assets: decreased 2.26% in 2022 and later soared 97.58% in 2025.
  • Eli Lilly's Current Assets stood at $18.0 billion in 2022, then soared by 42.65% to $25.7 billion in 2023, then increased by 27.26% to $32.7 billion in 2024, then surged by 69.91% to $55.6 billion in 2025, then dropped by 1.43% to $54.8 billion in 2026.
  • The last three reported values for Current Assets were $54.8 billion (Q1 2026), $55.6 billion (Q4 2025), and $62.1 billion (Q3 2025) per Business Quant data.